{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:44:24Z","timestamp":1772192664116,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.tem.2005.09.002","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T20:49:39Z","timestamp":1129668579000},"page":"401-406","source":"Crossref","is-referenced-by-count":23,"title":["Aldosterone: good guy or bad guy in cerebrovascular disease?"],"prefix":"10.1016","volume":"16","author":[{"given":"Christin\u00e9 S","family":"Rigsby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E","family":"Cannady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M","family":"Dorrance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2005.09.002_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5694\/j.1326-5377.1999.tb123654.x","article-title":"Preventing stroke: what is the real progress?","volume":"171","author":"Hankey","year":"1999","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.tem.2005.09.002_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.RVI.0000108687.75691.0C","article-title":"Pathophysiology of focal cerebral ischemia: a therapeutic perspective","volume":"15","author":"Smith","year":"2004","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.tem.2005.09.002_bib3","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(95)03559-P","article-title":"Glucocorticoid receptor, mineralocorticoid receptors, 11\u03b2-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies","volume":"111","author":"Roland","year":"1995","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2005.09.002_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.HYP.29.1.45","article-title":"Vascular aldosterone in genetically hypertensive rats","volume":"29","author":"Takeda","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2005.09.002_bib5","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1152\/physrev.1999.79.4.1431","article-title":"Ischemic cell death in brain neurons","volume":"79","author":"Lipton","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2005.09.002_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-0173(02)00157-1","article-title":"Cerebral ischemia and trauma \u2013 different etiologies yet similar mechanisms: neuroprotective opportunities","volume":"39","author":"Leker","year":"2002","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.tem.2005.09.002_bib7","first-page":"105","article-title":"Small artery remodeling and significance in the development of hypertension","volume":"17","author":"Mulvany","year":"2002","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.tem.2005.09.002_bib8","first-page":"S7","article-title":"Effects of angiotensin-converting enzyme inhibitors on cerebral vascular structure in chronic hypertension","volume":"18","author":"Baumbach","year":"2000","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.tem.2005.09.002_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000051184","article-title":"A review on blood pressure and ischaemic white matter lesions","volume":"9","author":"Skoog","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"suppl.1","key":"10.1016\/j.tem.2005.09.002_bib10","first-page":"143","article-title":"Establishment of the stroke-prone spontaneously hypertensive rats (SHR)","volume":"34","author":"Okamoto","year":"1974","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2005.09.002_bib11","doi-asserted-by":"crossref","first-page":"R944","DOI":"10.1152\/ajpregu.2001.281.3.R944","article-title":"Spironolactone reduces cerebral infarct size and epidermal growth factor receptor mRNA in stroke-prone rats","volume":"281","author":"Dorrance","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp Physiol."},{"key":"10.1016\/j.tem.2005.09.002_bib12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.HYP.13.6.968","article-title":"Remodeling of cerebral arterioles in chronic hypertension","volume":"13","author":"Baumbach","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2005.09.002_bib13","first-page":"258","article-title":"Impaired dilatation of cerebral arterioles in chronic hypertension","volume":"27","author":"Heistad","year":"1990","journal-title":"Blood Vessels"},{"key":"10.1016\/j.tem.2005.09.002_bib14","first-page":"H1027","article-title":"Mechanics of large and small cerebral arteries in chronic hypertension","volume":"266","author":"Hajdu","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.tem.2005.09.002_bib15","first-page":"505","article-title":"Vascular remodeling","volume":"28","author":"Mulvany","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2005.09.002_bib16","doi-asserted-by":"crossref","first-page":"H1489","DOI":"10.1152\/ajpheart.00352.2003","article-title":"Myogenic and structural properties of cerebral arteries from the stroke-prone spontaneously hypertensive rat","volume":"285","author":"Izzard","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tem.2005.09.002_bib17","doi-asserted-by":"crossref","first-page":"II15","DOI":"10.1161\/01.HYP.18.4_Suppl.II15","article-title":"Effects of antihypertensive treatment on composition of cerebral arterioles","volume":"18","author":"Hajdu","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2005.09.002_bib18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.HYP.33.3.856","article-title":"Effects of an angiotensin-converting enzyme inhibitor and a \u03b2-blocker on cerebral arterioles in rats","volume":"33","author":"Chillon","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2005.09.002_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from an analysis of 145 cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.tem.2005.09.002_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","article-title":"Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2005.09.002_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.crd.0000096417.42861.ce","article-title":"Glucocorticoid-remediable aldosteronism","volume":"12","author":"McMahon","year":"2004","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.tem.2005.09.002_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","article-title":"Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan","volume":"18","author":"Takeda","year":"1995","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.tem.2005.09.002_bib23","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1592\/phco.24.11.1064.36137","article-title":"Angiotensin-converting enzyme inhibitors and stroke risk: benefit beyond blood pressure reduction?","volume":"24","author":"Hilleman","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tem.2005.09.002_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000130360.21618.D0","article-title":"Modulation of the rennin\u2013angiotensin\u2013aldosterone system for the secondary prevention of stroke","volume":"63","author":"Sokol","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2005.09.002_bib25","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000064344.00173.44","article-title":"Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension?","volume":"41","author":"Connell","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2005.09.002_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissues","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2005.09.002_bib27","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/01.STR.28.9.1821","article-title":"The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats","volume":"28","author":"MacLeod","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.tem.2005.09.002_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-3565(24)35140-7","article-title":"Effect of poststroke captopril treatment on mortality associated with hemorrhagic stroke in stroke-prone rats","volume":"291","author":"Smeda","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tem.2005.09.002_bib29","doi-asserted-by":"crossref","first-page":"H435","DOI":"10.1152\/ajpheart.00262.2004","article-title":"From bedside to bench to bedside: role of rennin\u2013angiotensin\u2013aldosterone system in remodeling of resistance arteries in hypertension","volume":"287","author":"Schiffrin","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tem.2005.09.002_bib30","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1067\/mhj.2002.129971","article-title":"New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone","volume":"144","author":"Funder","year":"2002","journal-title":"Am. Heart J."},{"key":"10.1016\/j.tem.2005.09.002_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004872-200301000-00021","article-title":"Contribution of endogenous endothelin in the enhanced coronary constriction in DOCA-salt hypertensive rats","volume":"21","author":"Millette","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2005.09.002_bib32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/00004872-200205000-00025","article-title":"Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE\/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats","volume":"20","author":"Pu","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2005.09.002_bib33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1440-1681.2001.03461.x","article-title":"A proteasome inhibitor prevents vascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats","volume":"28","author":"Takaoka","year":"2001","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.tem.2005.09.002_bib34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1248\/bpb.23.820","article-title":"Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats","volume":"23","author":"Kuro","year":"2000","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.tem.2005.09.002_bib35","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.ATV.17.6.1152","article-title":"Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats","volume":"17","author":"Benetos","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2005.09.002_bib36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2005.09.002_bib37","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.HYP.0000128031.31572.a3","article-title":"Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats","volume":"43","author":"Endemann","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2005.09.002_bib38","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/01.STR.0000129788.26346.18","article-title":"Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats","volume":"35","author":"Ando","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.tem.2005.09.002_bib39","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocorticoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2005.09.002_bib40","unstructured":"Rigsby, C.S. and Dorrance, A.M. (2004) Spironolactone increases lumen diameter in the middle cerebral artery of spontaneously hypertensive stroke-prone rats (SHRSP). Hypertension 44, 536:P110"},{"key":"10.1016\/j.tem.2005.09.002_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000072029","article-title":"Participation of the mineralocorticoid receptor in cardiac and vascular remodeling","volume":"94","author":"Fiebeler","year":"2003","journal-title":"Nephron Physiol."},{"key":"10.1016\/j.tem.2005.09.002_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.12.010","article-title":"RALES, EPHESUS and redox","volume":"93","author":"Funder","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2005.09.002_bib43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","article-title":"Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?","volume":"44","author":"Touyz","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2005.09.002_bib44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1440-1681.2003.03867.x","article-title":"Extra-adrenal production of corticosteroids","volume":"30","author":"Davies","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.tem.2005.09.002_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00041552-200403000-00007","article-title":"Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease","volume":"13","author":"Gomez-Sanchez","year":"2004","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.tem.2005.09.002_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1196\/annals.1286.035","article-title":"11\u03b2-Hydroxysteroid dehydrogenases in the brain: two enzymes two roles","volume":"1007","author":"Holmes","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tem.2005.09.002_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-7207(03)00094-7","article-title":"The functional roles of 11\u03b2-HSD1: vascular tissue, testis and brain","volume":"203","author":"Morris","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2005.09.002_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(00)00677-4","article-title":"The brain mineralocorticoid receptor: greedy for ligand, mysterious in function","volume":"405","author":"Reul","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tem.2005.09.002_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.tem.2005.09.002_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/REVNEURO.2002.13.1.59","article-title":"Corticosteroids: sculptors of the hippocampal formation","volume":"13","author":"Sousa","year":"2002","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.tem.2005.09.002_bib51","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/endo-117-6-2505","article-title":"Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation","volume":"117","author":"Reul","year":"1985","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2005.09.002_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(90)90433-C","article-title":"Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid","volume":"514","author":"Spencer","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.tem.2005.09.002_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(00)01368-9","article-title":"Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain","volume":"291","author":"Biebl","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tem.2005.09.002_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hipo.450050103","article-title":"Dentate gyrus destruction and spatial learning impairment after corticosteroid removal in young and middle-aged rats","volume":"5","author":"Conrad","year":"1995","journal-title":"Hippocampus"},{"key":"10.1016\/j.tem.2005.09.002_bib55","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0306-4522(94)90224-0","article-title":"Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus","volume":"61","author":"Cameron","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.tem.2005.09.002_bib56","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.2911756","article-title":"Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy","volume":"243","author":"Sloviter","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.tem.2005.09.002_bib57","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0006-8993(02)03042-1","article-title":"The prototypic mineralocorticoid receptor agonist aldosterone influences neurogenesis in the dentate gyrus of the adrenalectomized rat","volume":"947","author":"Fischer","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.tem.2005.09.002_bib58","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1111\/j.1460-9568.2004.03717.x","article-title":"The corticoid environment: a determining factor for neural progenitors' survival in the adult hippocampus","volume":"20","author":"Wong","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tem.2005.09.002_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jnr.1076","article-title":"Adrenocorticosteroid receptor blockade and excitotoxic challenge regulate adrenocorticosteroid receptor mRNA levels in hippocampus","volume":"64","author":"McCullers","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tem.2005.09.002_bib60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F","article-title":"Overexpression of Bcl-2 is neuroprotective after experimental brain injury in transgenic mice","volume":"412","author":"Nakamura","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tem.2005.09.002_bib61","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1097\/00001756-199809140-00031","article-title":"Mineralocorticoid receptors regulate bcl-2 and p53 mRNA expression in hippocampus","volume":"9","author":"McCullers","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.tem.2005.09.002_bib62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0306-4522(01)00477-8","article-title":"Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat","volume":"109","author":"McCullers","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.tem.2005.09.002_bib63","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1096\/fasebj.14.5.779","article-title":"Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate","volume":"14","author":"Almeida","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2005.09.002_bib64","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1046\/j.1460-9568.2003.02587.x","article-title":"Mineralocorticoid receptor expression and increased survival following neuronal injury","volume":"17","author":"Macleod","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tem.2005.09.002_bib65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0006-8993(99)01354-2","article-title":"Increase in apoptosis and concomitant reduction of ischemic lesion volume and evidence for synaptogenesis after transient focal cerebral ischemia in rat treated with staurosporine","volume":"828","author":"Chopp","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.tem.2005.09.002_bib66","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/01.STR.0000126118.44249.5c","article-title":"Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us?","volume":"35","author":"Krieger","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.tem.2005.09.002_bib67","doi-asserted-by":"crossref","first-page":"H423","DOI":"10.1152\/ajpheart.00685.2001","article-title":"The rennin\u2013angiotensin\u2013aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure","volume":"283","author":"Zhang","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Trends in Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276005002110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276005002110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T01:26:05Z","timestamp":1736040365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276005002110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S1043276005002110"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2005.09.002","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}